Acorn Bioventures, L.P. is of Reneo Pharmaceuticals, Inc.. Currently has a direct ownership of 1.71 Million shares of RPHM, which is worth approximately $2.87 Million. The most recent transaction as insider was on May 15, 2025, when has been sold 270,270 shares (Common Stock) at a price of $1.85 per share, resulting in proceeds of $499,999. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.71M
n/a 3M change
n/a 12M change
Total Value Held $2.87 Million

ACORN BIOVENTURES, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 15 2025
BUY
Open market or private purchase
$499,999 $1.85 p/Share
270,270 Added 13.65%
1,709,944 Common Stock
ABL

Acorn Bioventures, L.P.

New York, NY

Track Institutional and Insider Activities on RPHM

Follow Reneo Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RPHM shares.

Notify only if

Insider Trading

Get notified when an Reneo Pharmaceuticals, Inc. insider buys or sells RPHM shares.

Notify only if

News

Receive news related to Reneo Pharmaceuticals, Inc.

Track Activities on RPHM